Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000902663 | SCV001047094 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888509 | SCV004705717 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV000902663 | SCV005306250 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000114376 | SCV000147990 | pathogenic | Retinitis pigmentosa 68 | 2014-03-27 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000114376 | SCV001142333 | uncertain significance | Retinitis pigmentosa 68 | 2020-01-06 | no assertion criteria provided | curation | NM_020949.2:c.1391G>T in the SLC7A14 gene has an allele frequency of 0.013 in East Asian subpopulation in the gnomAD database. It has been reported previously in individuals with retinitis pigmentosa, including one homozygous and one compound heterozygote (PMID: 24670872). We interpret it as variant of uncertain significance (VUS). ACMG/AMP criteria applied: PM3, BS1. |
Prevention |
RCV003925105 | SCV004738761 | likely benign | SLC7A14-related disorder | 2019-07-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |